PathAI

@Path_AI

Transforming Pathology

Boston, MA
Vrijeme pridruživanja: ožujak 2016.

Tweetovi

Blokirali ste korisnika/cu @Path_AI

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Path_AI

  1. proslijedio/la je Tweet
    29. sij

    Very fun turn out for ’s Teresa Borcuch and her talk about using coding challenges to hire data scientists. Look at how much fun everyone is having!

    Poništi
  2. 22. sij

    Today we welcomed 20 students to our office to talk more about PathAI, what it's like working at a start-up, and meet some of members of our team!

    Poništi
  3. proslijedio/la je Tweet

    This week at the , the MLSC convened various stakeholders to discuss how is rapidly changing patient care. Thank you to our panelists and to attendees for being part of the gathering. 🔗

    Poništi
  4. proslijedio/la je Tweet
    13. pro 2019.
    Poništi
  5. proslijedio/la je Tweet
    22. stu 2019.

    "... there was no call for the use of these tools from practicing clinicians. Few physicians ... received training in quantitative methods; therefore, they neither saw a need for probabilistic estimates, nor could they properly apply them ..."

    Prikaži ovu nit
    Poništi
  6. 14. stu 2019.

    We are so excited to welcome Michael Montalto to the PathAI family as Chief Scientific Officer! Mike worked closely with us during his role at BMS, bringing a ton of experience in biomarkers, imaging discovery, & IVDs—the perfect new addition to the team!

    Poništi
  7. proslijedio/la je Tweet

    At , we're presenting findings with that showcase the potential of AI-powered and immune cell pathology analyses.

    Poništi
  8. proslijedio/la je Tweet

    Improving the accuracy of diagnosis and monitoring is crucial to better understanding the disease. We’re working with to advance methods for interpreting liver histology and characterizing disease progression.

    Poništi
  9. 8. stu 2019.

    NASH is an incredibly impactful disease, and has been doing a ton of work toward understanding its mechanism and producing potential treatments. We're excited to play a core role in helping accelerate and amplify their research efforts:

    Prikaži ovu nit
    Poništi
  10. 8. stu 2019.

    If you thought we only worked on cancer, we've got even more news for you this week. Today marks the opening of here in Boston, and we're sharing the results of two NASH-related research efforts with our partners at :

    Prikaži ovu nit
    Poništi
  11. proslijedio/la je Tweet

    Through a collaboration with , we're showcasing results from the first AI-powered analysis of PD-L1 expression across three Phase 3 trials at .

    Poništi
  12. proslijedio/la je Tweet
    5. stu 2019.
    Poništi
  13. proslijedio/la je Tweet
    5. stu 2019.

    To most folks, this is gobbledygook. But once you peel back the jargon, you can see that we (& our partners) are making inroads into some of the keys to what I think of as science's current-best-hope to cure cancer. Here's how I think about this, coming from the tech side… 1/

    Prikaži ovu nit
    Poništi
  14. 5. stu 2019.

    More big news this week: We're announcing research at ! Among the highlights: accurate tumor & immune cell PD-L1 quantification and similar patient response prediction across three phase 3 lung cancer trials of Opdivo (nivolumab), with

    Poništi
  15. 4. stu 2019.

    How often can you say that the two of the biggest names in pharmaceuticals agreed on the same thing? We are honored that and have invested in PathAI and our mission:

    Poništi
  16. 11. lis 2019.

    Our very own VP of Regulatory & Clincal Affairs, Esther Abels, speaking at ! Don't miss her article and the associated white paper she authored on the regulatory impacts on digital pathology:

    Poništi
  17. 5. lis 2019.
    Poništi
  18. 2. lis 2019.

    We're so excited to meet so many fantastic women in tech at ! Stop by booth 477 to find out more about us and ways we could work together: And make sure to RSVP to our happy hour!

    Poništi
  19. proslijedio/la je Tweet
    17. ruj 2019.

    Sitting at my desk here , I'm surrounded on all sides by women – and I'm including the diagonals. Pretty amazing for a tech company, and unique so far in my career. Most of all, great progress from where we were just a couple years ago.

    Poništi
  20. proslijedio/la je Tweet
    18. ruj 2019.

    Django Boston Meetup has two great talks tomorrow hosted at . is doing a talk on adding Search to any Django project. will be doing a talk on how Masschallenge upgraded their entire system from legacy python to Python 3.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·